📰 Forefront Analytics News
Page 15 - Forefront Analytics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forefront Analytics. Real-time updates on events, politics, business and more.
April 14, 2023
Should You Buy or Sell iShares 3-7 Year Treasury Bond ETF Stock? Get The Latest IEI Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.
April 11, 2023
PrairieView Partners LLC grew its position in iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI – Get Rating) by 29.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,171 shares of the company’s stock after purchasing an additional 492 shares during the quarter. PrairieView […]
April 4, 2023
S. R. Schill & Associates reduced its position in shares of iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI – Get Rating) by 4.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,226 shares of the company’s stock after selling 224 […]
April 3, 2023
Dyadic International, Inc. (NASDAQ:DYAI – Get Rating) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 447,200 shares, a growth of 5.1% from the February 28th total of 425,700 shares. Currently, 2.2% of the shares of the stock are short sold. Based on […]
April 2, 2023
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Rating) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 3,040,000 shares, a decrease of 12.1% from the February 28th total of 3,460,000 shares. Based on an average daily volume of 3,800,000 shares, the […]
April 2, 2023
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 3,040,000 shares, a drop of 12.1% from the February 28th total of 3,460,000 shares. Based on an average trading volume of 3,800,000 shares, the […]
April 1, 2023
Codiak BioSciences, Inc. (NASDAQ:CDAK – Get Rating) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 173,800 shares, a growth of 25.6% from the February 28th total of 138,400 shares. Based on an average trading volume of 176,800 shares, the days-to-cover ratio is […]
March 31, 2023
Codiak BioSciences, Inc. (NASDAQ:CDAK – Get Rating) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 173,800 shares, a growth of 25.6% from the February 28th total of 138,400 shares. Based on an average daily volume of 176,800 shares, the […]
March 31, 2023
Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) saw a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 6,300 shares, a decrease of 33.7% from the February 28th total of 9,500 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average […]
March 25, 2023
StockNews.com lowered shares of CytomX Therapeutics (NASDAQ:CTMX – Get Rating) from a hold rating to a sell rating in a report published on Friday morning. Separately, BMO Capital Markets increased their price target on CytomX Therapeutics from $2.60 to $3.20 and gave the company a market perform rating in a report on Friday, January 6th. […]